All companies
Visit website
GRYT HEALTH, INC
OperatingGRYT Health Inc
Healthcare · Founded 2016
Increasing access to new cancer treatments
Post-money valuation ⓘ
$18.1M
As of Apr 2025 · from GRYT HEALTH, INC Preferred Stock 1 · pre-money + amount raised, not a traded price
Total raised
$78,632
Across 1 round since 2024
Latest share price
$7,817.59
GRYT HEALTH, INC Preferred Stock 1 offering price
Financials
FY2022–FY2024 · from SEC filings · hover any figure for its source$2.5M
−$1.7M
2022
$2.2M
−$1.8M
2023
$1.7M
−$710K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
FY2024
Income statement
Revenue
$2,451,817
$2,228,199
$1,703,081
Cost of goods sold
$0
$1,442,982
$803,526
Gross margin
100%
35%
53%
Net income
-$1,682,599
-$1,830,276
-$709,649
Taxes paid
-$192,674
$552,850
-$2,681
Balance sheet
Cash
$11,667
$368
$7,463
Accounts receivable
$307,458
$277,971
$108,389
Total assets
$1,116,268
$485,609
$319,738
Short-term debt
$1,523,858
$314,982
$277,378
Long-term debt
$0
$0
$0
Total liabilities
$1,523,858
$314,982
$277,378
Other
Headcount
—
18
12
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$18.1M
post-money
GRYT HEALTH, INC Preferred Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $78.6K / $750.5KPost-money $18.1M
Reg CF annual-report compliance
Possibly delinquent
Filed 1 of 2 annual reports (FY2024–FY2025)
Missing: 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001871680Share price $7,817.59
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.